| Deoxycholic Acid Injection for the Treatment of Superficial Lipomas | Phase 1, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Sequential Dose-Escalation Study of the Pharmacokinetics, Safety, and Efficacy of ATX-101 (Sodium Deoxycholate for Injection) Intralipomal Injections for the Treatment of Superficial Lipomas | NCT00422188 |
| Safety and Efficacy of Deoxycholic Acid Injection for Reduction of Upper Inner Thigh Fat | Safety and Efficacy of Deoxycholic Acid Injection for Reduction of Upper Inner Thigh Fat | NCT04054011 |
| "Efficacy and Safety of Deoxycholic Acid Injections for Removal of Adipose Tissue in the ""Bra Strap Fat"" Region" | "Efficacy and Safety of Deoxycholic Acid Injections for Removal of Adipose Tissue in the Anterior and Posterior Aspect of the Axilla ""Bra Strap Fat""" | NCT04089722 |
| The PK/PD of Deoxycholic Acid Amphotericin B in Invasive Fungal Infection Patients With Sepsis/Septic Shock | The PK/PD of Deoxycholic Acid Amphotericin B in Invasive Fungal Infection Patients With Sepsis/Septic Shock | NCT05642624 |
| Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area | Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of ATX-101 (Sodium Deoxycholate Injection) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area | NCT01542034 |
| Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area | Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of ATX-101 (Sodium Deoxycholate Injection) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area | NCT01546142 |
| Deoxycholic Acid Injection Submental Fat (SMF) Magnetic Resonance Imaging (MRI) and Subject-reported Outcome Measures Study | Multicenter, Randomized, Double-blind, Placebo-controlled Study of ATX-101 (Sodium Deoxycholate Injection) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area (SMF) Using Magnetic Resonance Imaging (MRI) and a Battery of Clinician- and Subject-reported Measurements. | NCT01032889 |
| Evaluating the Efficacy and Safety of Embella (Deoxycholic Acid, Produced by Espad Pharmed Co.) for the Treatment of Flank Fat | Evaluating the Efficacy and Safety of Embella (Deoxycholic Acid, Produced by Espad Pharmed Co.) for the Treatment of Flank Fat | NCT07004010 |
| Evaluating the Efficacy and Safety of Embella (Deoxycholic Acid, Produced by Espad Pharmed Co.) Injection in the Management of Superficial Lipomas | Evaluating the Efficacy and Safety of Embella (Deoxycholic Acid, Produced by Espad Pharmed Co.) Injection in the Management of Superficial Lipomas | NCT07014163 |
| Open-Label Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area | Multicenter, Open-label Study of ATX-101 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area | NCT01426373 |
| Safety Study of ATX-101 (Deoxycholic Acid) in Subjects With Mild or Extreme Fullness of Submental Fat | A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid) Injection for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR-SMFRS) Grade 1 or CR-SMFRS Grade 4 | NCT02035267 |
| Patient Experience Study of Deoxycholic Acid Injection | A Single Center, Double-blind, Parallel-group, Two Factor Patient-Experience Management Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area | NCT02007434 |
| Evaluation of an injectable solution with the brand name ®Embella in order to reduce submental fat. | Evaluation of safety and effectiveness of an injectable solution containing deoxycholic acid with the brand name ®Embella, in order to reduce submental fat. | IRCT20190210042676N29 |
| Deoxycholic acid as treatment of abdominal fat | Deoxycholic acid as treatment of abdominal adiposity | ACTRN12618001775202 |
| Effectiveness and Safety Evaluation of Embella (Deoxycholic Acid, by Espad Pharmed Co.) in Management of Submental Fat | Evaluating the Effectiveness and Safety of Embella (Deoxycholic Acid, Produced by Espad Pharmed Co.) for the Management of Submental Fat | NCT06509438 |
| The efficacy and safety of Deoxycholic acid injection in reduction of flank fat | Evaluating the efficacy and safety of Deoxycholic acid injection (Embella®) in reduction of flank fat | IRCT20240416061507N1 |
| Evaluating the efficacy and safety of (Embella®) in management of superficial lipomas | Evaluating the efficacy and safety of Deoxycholic acid injection (Embella®) in management of superficial lipomas | IRCT20240416061507N2 |
